California Governor Gavin Newsom has mocked White House Press Secretary Karoline Leavitt‘s statement about Donald Trump’s signing of an executive order for the use of psychedelic drugs. The social media handle representing the former mayor of San Francisco recently issued an amusing response to Leavitt’s promotion of the president’s decree, ridiculing Donald Trump’s own mental health.
Gavin Newsom roasts Karoline Leavitt in new post
On April 20, the X (formerly Twitter) account of Gavin Newsom’s press office made fun of Donald Trump’s latest mental health order by replying to one of Leavitt’s tweets.
Newsom‘s taunt comes after the political spokeswoman shared a White House ‘Fact Sheet’ detailing Trump’s directive about psychedelics via her X profile. “President Donald J. Trump is Accelerating Medical Treatments for Serious Mental Illness,” the White House press secretary wrote in the caption of the post.
Gavin Newsom was quick to pounce on the missing information in Karoline Leavitt’s message about the potential beneficiaries of Donald Trump’s mental health order. He simply reposted Leavitt’s tweet along with the caption, “For himself?” throwing shade at the president’s mental acuity in the process.
Notably, many high-profile personalities, including long-time advocates of Donald Trump, have questioned the president’s sanity following his continued aggression towards Iran, as well as his recent scuffle with Pope Leo XIV.
Following Gavin Newsom’s footsteps, a host of politically inclined individuals hopped on X to mock Karoline Leavitt’s statement. Bakari Sellers, a Democrat and former member of the South Carolina House of Representatives, noted, “Thank GOD, he’s getting the help he needs.” Meanwhile, renowned journalist Aaron Rupar shared a similar quip on his X profile, writing, “we’ve noticed and i’m glad he’s getting help,” in response to Leavitt.
Donald Trump signed the executive order in question on April 18, which directed the FDA to support clinical trials for psychedelics, while also overseeing a smooth and swift approval process of such drugs.
Originally reported by Apoorv Rastogi on Mandatory.
